Recent Finacing
Recent Raise
Relmada Therapeutics is a clinical-stage company developing chronic pain therapies including LevoCap ER (once-daily levorphanol Phase III), d‑methadone for diabetic neuropathy (Phase IIb), BuCap and MepiGel in PK studies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
